MTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO MTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS

Anft Moritz; Roch Toralf; Wehler Patrizia; Stervbo Ulrik; Viebahn Richard; Westhoff Timm; Choi Mira; Babel Nina

首页> 外文期刊>Transplant international : >MTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO MTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS

【24h】

MTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO MTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS

机译：基于MTOR抑制剂的免疫抑制与肾移植患者的MTOR抑制剂治疗相比，与IFNγ的IFNγ的EBV特异性CD4（+）T细胞的较高频率相关联

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplant international :》 |2019年第s2期|共1页
作者
Anft Moritz; Roch Toralf; Wehler Patrizia; Stervbo Ulrik; Viebahn Richard; Westhoff Timm; Choi Mira; Babel Nina;
展开▼
作者单位

Marien Hosp Herne Herne Germany;

Charite Berlin Germany;

Charite Berlin Germany;

Marien Hosp Herne Herne Germany;

Knappschaftkrankenhaus Bochum Bochum Germany;

Marien Hosp Herne Herne Germany;

Charite Berlin Germany;

Marien Hosp Herne Herne Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词

相似文献

外文文献
中文文献
专利

1. mTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO mTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS [J] . Moritz A., Roch T., Wehler P., Transplant international : . 2019,第S3期

机译：基于MTOR抑制剂的免疫抑制与肾移植患者的MTOR抑制剂治疗相比，与IFNγ的IFNγ的EBV特异性CD4（+）T细胞的较高频率相关联
2. Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease [J] . Gaudre N., Cougoul P., Bartolucci P., American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2017,第8期

机译：改善胎儿血红蛋白的MTOR抑制剂的免疫抑制在肾移植受体中的免疫抑制因子镰状细胞疾病
3. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients [J] . Susan L. Murray, Fergus E. Daly, Patrick O’Kelly, Renal failure. . 2020,第1期

机译：切换到MTOR抑制剂的免疫抑制对肾脏和肝移植受者的长期非黑色素瘤皮肤癌发病率和肾功能的影响
4. Achieving cancer cell death with PI3K/mTOR-targeted therapies [C] . Sung Su Yea, David A. Fruman Inositol Phospholipid Signaling in Physiology and Disease (Conference) . 2013

机译：用PI3K / MTOR靶向疗法实现癌症细胞死亡
5. A Retrospective Analysis of Renal Transplant Outcomes: induction Immunosuppression with Anti-thymocyte Globulin vs. Alemtuzumab in patients undergoing Deceased and Living Donor Kidney Transplantation. [D] . DiMartino, Debra A. 2012

机译：肾移植结果的回顾性分析：死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
6. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients [O] . Susan L. Murray, Fergus E. Daly, Patrick O’Kelly, 2020

机译：切换到MTOR抑制剂的免疫抑制对肾脏和肝移植受者的长期非黑色素瘤皮肤癌发病率和肾功能的影响
7. Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: A novel approach for tailored immunosuppressive therapy [O] . Hartmann Bertram, Schmid Gerald, Graeb Christian, 2005

机译：肾脏移植后基于mTOR抑制剂的免疫抑制的生化监测：量身定制的免疫抑制疗法的新方法

MTOR INHIBITOR-BASED IMMUNOSUPPRESSION IS ASSOCIATED WITH A HIGHER FREQUENCY OF IFN gamma-PRODUCING EBV-SPECIFIC CD4(+) T CELLS AS COMPARED TO MTOR INHIBITOR-FREE THERAPY IN KIDNEY TRANSPLANT PATIENTS

著录项

相似文献

相关主题

期刊订阅